Capital International Investors
GMAB icon

Capital International Investors’s Genmab GMAB Stock Holding History

Capital International Investors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,570,909
Closed -$53.4M – 451
2024
Q4 		$53.4M Sell
2,570,909
-1,850,708
-42% -$40.7M 0.01% 335
2024
Q3 		$108M Buy
4,421,617
+193,652
+5% +$5.18M 0.02% 266
2024
Q2 		$108M Sell
4,227,965
-145,312
-3% -$4.12M 0.02% 257
2024
Q1 		$131M Buy
4,373,277
+315,355
+8% +$9.26M 0.03% 260
2023
Q4 		$130M Sell
4,057,922
-260,420
-6% -$8.18M 0.03% 259
2023
Q3 		$153M Buy
4,318,342
+121,282
+3% +$4.62M 0.04% 236
2023
Q2 		$157M Buy
4,197,060
+88,355
+2% +$3.52M 0.04% 252
2023
Q1 		$154M Buy
4,108,705
+61,869
+2% +$2.38M 0.04% 254
2022
Q4 		$172M Sell
4,046,836
-799,460
-16% -$32.9M 0.05% 252
2022
Q3 		$155M Buy
4,846,296
+149,201
+3% +$5.24M 0.05% 256
2022
Q2 		$149M Buy
4,697,095
+744,649
+19% +$24.1M 0.04% 262
2022
Q1 		$145M Buy
3,952,446
+283,031
+8% +$9.71M 0.03% 276
2021
Q4 		$146M Sell
3,669,415
-27,120
-0.7% -$1.13M 0.03% 293
2021
Q3 		$157M Buy
3,696,535
+169,379
+5% +$7.6M 0.04% 265
2021
Q2 		$146M Buy
3,527,156
+260,648
+8% +$10.1M 0.03% 270
2021
Q1 		$104M Buy
3,266,508
+365,464
+13% +$13.7M 0.03% 283
2020
Q4 		$118M Buy
2,901,044
+366,152
+14% +$13.7M 0.03% 269
2020
Q3 		$94.6M Sell
2,534,892
-65,032
-3% -$2.35M 0.03% 265
2020
Q2 		$84.9M Buy
+2,599,924
New +$70.8M 0.03% 267

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $10.6B AUM 19.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors's GMAB Position: Q1 2025 in Review

Capital International Investors sold out of Genmab (GMAB) in Q1 2025, closing a stake of 2,570,909 shares — an estimated $53.4M sold.

Capital International Investors first reported a position in GMAB in Q2 2020 and held it in 19 quarters. The position peaked at $172M in Q4 2022. 220 funds tracked by Wall St. Rank hold GMAB as of Q1 2025.

  • Capital International Investors reported no remaining Genmab position as of Q1 2025 after selling out during the quarter.
  • Capital International Investors sold 2,570,909 Genmab shares in Q1 2025, an estimated $53.4M.
  • Capital International Investors first reported a position in Genmab in Q2 2020 and held it in 19 quarters.
  • Capital International Investors's Genmab position peaked at $172M in Q4 2022.
  • 220 funds tracked by Wall St. Rank held Genmab as of Q1 2025.

Based on Capital International Investors's 13F filing for Q1 2025, filed 12 May 2025.